Compare
5 stocks, side by sideRelative performance · rebased to 100
RVMDALNYRPRXONCARGX
| RVMDRevolution Medicines, Inc. | ALNYAlnylam Pharmaceuticals, Inc. | RPRXRoyalty Pharma plc | ONCBeOne Medicines AG | ARGXargenx SE | |
|---|---|---|---|---|---|
| Smart Score | 10/10 | 8/10 | 7/10 | 8/10 | 7/10 |
| Price | $178.17 | $293.17 | $54.69 | $275.34 | $888.65 |
| 1 month | +15% | -0.79% | +1.5% | -9.0% | +9.9% |
| 1 year | +345% | -9.8% | +55% | +3.2% | +56% |
| 5 year | +423% | +70% | +39% | -16% | +182% |
| P/E (TTM) | -27.6 | 67.8 | 29.3 | 50.9 | 37.1 |
| P/E vs sector | - | +115% | -7% | +62% | +18% |
| Market cap | $37.9B | $39.1B | $31.5B | $28.6B | $55.5B |
| Sector | Healthcare | Healthcare | Healthcare | Healthcare | Healthcare |
Risk / Return · past yearAnnualized return vs volatility, up-and-left is more reward for less risk.
Correlation · do they move together?Pairwise daily-return correlation over the past year, high = one bet, low = diversifying.